Growth Metrics

OmniAb (OABI) Goodwill & Intangibles (2021 - 2026)

OmniAb (OABI) reported Goodwill & Intangibles of $203.1 million for Q1 2026, down 7.18% year-over-year from $218.8 million in Q1 2025, and down 2.88% on a QoQ basis from $209.1 million in Q4 2025.

OmniAb (OABI) has 6 years of Goodwill & Intangibles data on file, last reported at $203.1 million in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 7.18% year-over-year to $203.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203.1 million (down 7.18% YoY) and the FY2025 annual result came in at $209.1 million, down 5.81% from the prior year.
  • Goodwill & Intangibles slipped to $203.1 million in Q1 2026 per OABI's latest filing, from $209.1 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $251.2 million in Q4 2022 and bottomed at $203.1 million in Q1 2026.
  • The 5-year median for Goodwill & Intangibles is $229.8 million (2024), against an average of $228.9 million.
  • The widest annual swing landed in 2022, when Goodwill & Intangibles fell 3.49%; it then dropped 7.3% in 2025.
  • Tracing OABI's Goodwill & Intangibles over 5 years: stood at $251.2 million in 2022, then fell by 4.69% to $239.4 million in 2023, then dropped by 7.27% to $222.0 million in 2024, then slipped by 5.81% to $209.1 million in 2025, then decreased by 2.88% to $203.1 million in 2026.
  • Per Business Quant, the three latest OABI Goodwill & Intangibles figures stand at $203.1 million (Q1 2026), $209.1 million (Q4 2025), and $212.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 203.10 Mn
Dec 31, 2025 209.13 Mn
Sep 30, 2025 212.36 Mn
Jun 30, 2025 215.58 Mn
Mar 31, 2025 218.81 Mn
Dec 31, 2024 222.04 Mn
Sep 30, 2024 228.10 Mn
Jun 30, 2024 231.49 Mn
Mar 31, 2024 236.03 Mn
Dec 31, 2023 239.45 Mn
Sep 30, 2023 242.75 Mn
Jun 30, 2023 245.90 Mn
Mar 31, 2023 248.33 Mn
Dec 31, 2022 251.22 Mn
Dec 31, 2021 260.30 Mn